THROMBIN AND THE THROMBIN THROMBOMODULIN COMPLEX INTERACTION WITH PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1

被引:5
|
作者
MADDEN, RM
LEVIN, EG
MARLAR, RA
机构
[1] UNIV COLORADO, HLTH SCI CTR,DEPT BIOCHEM,VET ADM MED CTR, LAB SERV 113,1055 CLERMONT AVE, DENVER, CO 80220 USA
[2] UNIV COLORADO, HLTH SCI CTR,DEPT PATHOL,VET ADM MED CTR,LAB SERV, DENVER, CO 80262 USA
[3] UNIV COLORADO, HLTH SCI CTR,DEPT PEDIAT,VET ADM MED CTR,LAB SERV, DENVER, CO 80262 USA
[4] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, COMM VASC BIOL, LA JOLLA, CA 92037 USA
关键词
FIBRINOLYSIS; PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1; THROMBIN; THROMBOMODULIN; PROTEIN-C;
D O I
10.1097/00001721-199106000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombin, the final enzyme of the coagulation system, also influences profibrinolytic activity by several mechanisms. These include cellular release of tissue plasminogen activator, activated protein C-induced fibrinolysis, and inactivation of plasminogen activator inhibitor, type 1 (PAI-1). In this report, the role of thrombin in the regulation of PAI-1 is investigated. Our studies demonstrate that thrombin inactivation of PAI-1 occurs via an enzymatic mechanism rather than an enzyme-inhibitor complex mechanism. Evidence to support this conclusion is: (1) concomitant analysis of PAI-1 and thrombin activities demonstrate decreased PAI-1 activity but no loss of thrombin activity; (2) no visible thrombin-PAI-1 complexes by SDS-PAGE analysis; and (3) lack of formation of I-125-thrombin - PAI-1 complexes. Thrombomodulin, a thrombin binding cofactor that modifies thrombin's functions, did not influence the inactivation of PAI-1 by thrombin. We propose that thrombin enzymatically inactivates PAI-1 without forming a stable enzyme-inhibitor complex. The reaction is not affected by thrombomodulin. Overall this reaction occurs so slowly that it is not physiologically relevant without some modifying factor(s).
引用
收藏
页码:471 / 476
页数:6
相关论文
共 50 条
  • [1] ACCELERATION OF THE THROMBIN INACTIVATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PROUROKINASE) BY THROMBOMODULIN
    DEMUNK, GAW
    GROENEVELD, E
    RIJKEN, DC
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05): : 1680 - 1684
  • [2] INACTIVATION OF RECEPTOR-BOUND PRO-UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PRO-UPA) BY THROMBIN AND THROMBIN/THROMBOMODULIN COMPLEX
    WILHELM, S
    WILHELM, O
    SCHMITT, M
    GRAEFF, H
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (09): : 603 - 608
  • [3] POSTOPERATIVE CHANGES IN PLASMA TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    AOKI, K
    NISHINO, N
    BABA, S
    URANO, T
    TAKADA, A
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (12): : 1039 - 1043
  • [4] The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin
    Braat, EAM
    Los, P
    Rijken, DC
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (05) : 419 - 427
  • [5] EFFECT OF ENDOTHELIN ON THE RELEASE OF TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM CULTURED HUMAN ENDOTHELIAL-CELLS AND INTERACTION WITH THROMBIN
    YAMAMOTO, C
    KAJI, T
    SAKAMOTO, M
    KOIZUMI, F
    THROMBOSIS RESEARCH, 1992, 67 (05) : 619 - 624
  • [6] Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin
    Marar, T. T.
    Boffa, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 772 - 783
  • [7] EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN CHRONIC PULMONARY THROMBOEMBOLI
    LANG, IM
    MARSH, JJ
    OLMAN, MA
    MOSER, KM
    LOSKUTOFF, DJ
    SCHLEEF, RR
    CIRCULATION, 1994, 89 (06) : 2715 - 2721
  • [8] Thrombin upregulates production of plasminogen activator inhibitor type 1 in human peritoneal mesothelial cells
    Mandl-Weber, S
    Haslinger, B
    Sitter, T
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (04): : 319 - 324
  • [9] NORMAL TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN PLASMA FROM PATIENTS WITH TYPE-1 DIABETES-MELLITUS
    VICARI, AM
    DANGELO, SV
    TESTA, S
    COMI, G
    GALARDI, G
    ORSI, E
    DANGELO, A
    HORMONE AND METABOLIC RESEARCH, 1992, 24 (11) : 516 - 519
  • [10] EFFECTS OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ON FIBRINOLYSIS INVITRO AND INVIVO
    KNABB, RM
    CHIU, AT
    REILLY, TM
    THROMBOSIS RESEARCH, 1990, 59 (02) : 309 - 317